Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
TopWeightLoss.ioTreatments Hub

Switching From Ozempic to Compounded Semaglutide

If you’re already injecting a GLP-1 and paying brand prices, this is the guide to moving to the same active ingredient at $49-$299/month - what actually happens, what the clinician decides, and what to verify before you move.

Last updated: Sep 1, 2026

Francheska Capistrano, Medical Content Reviewer

Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH

Reviewed · How we review

We may earn a commission from links on this page - it never affects our rankings (how we stay objective).

The short answer

Ozempic and Wegovy are semaglutide; Zepbound and Mounjaro are tirzepatide. Licensed telehealth providers prescribe compounded versions of the same molecules for $49-$299/month- versus $1,149-$1,599/month at brand list prices. Switching means completing the new provider’s medical intake, disclosing your current medication and dose, and letting its licensed clinician set your continuation dose. Start before your current supply runs out: approval-to-delivery takes between a day and a week depending on the provider.

The price gap, in real numbers

Brand list prices below are taken from our providers’ own brand-name shelves - not estimates. The compounded equivalents are in the index further down.

Brand drugActive ingredientBrand list priceCompounded from
OzempicSemaglutide$1,149-$1,399/mo

altRx $1,149 · wellmedr $1,399

$49/mo
ZepboundTirzepatide$1,249-$1,599/mo

altRx $1,249 · wellmedr $1,599

$89/mo
WegovySemaglutide$1,579-$1,799/mo

altRx $1,579 · Sprout $1,799

$49/mo

At the widest gap - Wegovy $1,579 vs wellmedr’s $49 semaglutide plan - the difference is over $18,000 a year. Compounded products are not FDA-approved brand drugs; the quality bar lives with the pharmacy, which is what the checklist below is for.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Most Popular
1
embody logo

Exceptional

9.8out of 10

Limited Offer - GLP-1 for $69/mon

Money-back guaranteeFree expedited delivery

Treatments offered

Compounded semaglutide injections (GLP-1) · Compounded tirzepatide injections (GLP-1 + GIP) · 100% online doctor review and prescription · Dosage adjustments through the patient portal

Starting price

$79$69/month

*Compounded medications are not FDA-approved.

  • Compounded semaglutide ($69/mo) and tirzepatide ($119/mo)
  • 5-minute health qualifier; doctor review usually within 24 hrs
  • Free 1-2 day shipping - temperature-controlled, tracked, insured
  • No insurance required, no clinic visits, cancel anytime

from $69/month

Visit SiteRead full review
3.8Trustpilot(8,398)

embody offers doctor-prescribed GLP-1 weight loss treatment - compounded semaglutide and tirzepatide injections - through a 100% online process. Getting started takes a roughly 5-minute health qualifier, after which a medical practitioner reviews your chart (embody says usually within 24 hours, often under 5). Pricing is flat and simple: $69/month for semaglutide and $119/month for tirzepatide, with no insurance required, no hidden fees, and no clinic visits. Medication ships in 1-2 days in temperature-controlled, tracked, insured packaging, and embody is LegitScript-certified and works with US-based 503A compounding pharmacies. On Trustpilot, embody averages 3.8 across 8,398 reviews - an honest, mixed-to-positive record whose recent reviews cluster around two themes: responsive, proactive customer service ('from my very first inquiry I've had excellent communication... customer service updated me every step,' writes one tirzepatide patient) and the no-surprises pricing ('Love the fact that there are no surprises as in costly up front cost'). A 3.7 also means a minority of customers had negative experiences - worth reading both ends of the reviews before deciding, as with any provider.

Read full embody review
2
altRx logo

Exceptional

9.7out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required

Treatments offered

Compounded semaglutide (GLP-1) injection · Compounded tirzepatide (GLP-1 + GIP) injection · Brand-name Zepbound and Wegovy · One simple injection per week

Starting price

$199$89/month

*Compounded medications are not FDA-approved.

  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

altRx bills itself as "the #1 most affordable GLP-1 program," and its published prices largely back that up: compounded GLP-1 (semaglutide) from $89/month and GLP-1 + GIP (tirzepatide) from $149/month - flat at every dose, so the price doesn't climb as you titrate up - alongside one of the few genuine brand-name shelves in this space (Ozempic $1,149, Zepbound $1,249, Wegovy $1,579 per month). It's a self-pay telehealth service: you complete a short assessment, a licensed provider (physician, PA, or nurse practitioner) reviews it, and if appropriate a prescription goes to a licensed US pharmacy, with free shipping in about 5-7 days. No insurance is required, Buy Now, Pay Later is available, and you can pause or cancel anytime. Two things to know before the details: shipping is slower than the 1-2 day providers (embody, DirectMeds), and Trustpilot does not currently display an aggregate score on altRx's profile - the individual reviews we quote on this page are real, but there's no independent average to lean on the way there is for rivals like Medvi (4.3 across 14,836) or embody (3.8 across 8,398). One of the real 4-star reviews we surface notes a refill 'yet to be fulfilled with zero reason as to why' - worth factoring in alongside the price advantage.

Read full altRx review

How the switch actually works

01

Pick the provider before you run out

Approval and first shipment take from a day to about a week depending on the provider (embody reviews chart-review in ~24 hours and ships in 1-2 days; altRx ships in 5-7 days). Start the switch while you still have one or two doses left so there's no gap in treatment.

02

Complete the intake - and disclose your current medication and dose

Every legitimate provider starts with a medical questionnaire. Report that you're currently on Ozempic, Wegovy or Zepbound and your exact current dose. This is the single most important step: it's what lets the reviewing clinician plan a continuation rather than treating you as a new starter.

03

A licensed clinician decides your starting dose

The new provider's clinician - not you, and not a sales page - decides whether to continue near your current dose or adjust. Don't assume a 1:1 continuation is automatic; it's a clinical decision based on your history, and reputable providers (HealthRx states it explicitly) never make approval automatic.

04

Your medication ships from a licensed pharmacy

Compounded semaglutide and tirzepatide ship as vials with syringes (some providers also offer needle-free formats - DirectMeds' sublingual drops, Medvi's dissolving tablets). Cold-chain shipping matters for injectables: embody and HealthRx ship temperature-controlled.

05

Keep the same weekly rhythm, watch how you respond

Dosing stays weekly for injectables, and side-effect expectations are the same molecule-for-molecule. If anything feels different as you transition, use the provider's check-ins - that follow-up layer is included in every program we rank.

Know your dose before the intake: the standard titration ladders

The intake will ask what you take and at what dose - answer from your pen or your pharmacy label, not from memory. For reference, these are the FDA-label titration schedules for the brand drugs people switch from:

Brand drugStarting doseEscalation stepsFull / maintenance dose
Wegovy (semaglutide)0.25 mg weekly, weeks 1-40.5 mg → 1 mg → 1.7 mg, stepping up every 4 weeks2.4 mg weekly
Ozempic (semaglutide)0.25 mg weekly, first 4 weeks0.5 mg, then 1 mg if neededup to 2 mg weekly
Zepbound / Mounjaro (tirzepatide)2.5 mg weekly, weeks 1-4increase in 2.5 mg steps, at least 4 weeks apart5, 10 or 15 mg weekly

Schedules from the drugs’ FDA prescribing information; your prescriber may have deviated from them. Compounded programs dose in the same molecule but their clinician sets your continuation dose individually - being mid-ladder on the brand doesn’t guarantee the same rung on the new program. Several providers charge the same price at every dose (wellmedr, altRx, DirectMeds, embody), so a higher continuation dose doesn’t have to cost more.

Side effects don’t change with the switch: the trial numbers

Compounded semaglutide and tirzepatide are the same active molecules, so the published side-effect profile is your best guide to what to expect - mostly digestive, mostly during dose increases, mostly easing as your body adjusts:

Reported eventSemaglutide 2.4 mg (STEP 1, 68 wks)Tirzepatide 5-15 mg (SURMOUNT-1, 72 wks)
Nausea~44%~25-33% across doses
Diarrhea~32%~19-23% across doses
Vomiting~25%~8-13% across doses
Constipation~23%~12-17% across doses

Approximate rates over the full trial periods, from the published STEP 1 and SURMOUNT-1 studies cited in the sources below; events were predominantly mild-to-moderate and concentrated around dose escalation. If you switch at your established dose rather than restarting the ladder, you may skip the roughest titration weeks - another reason the intake disclosure matters. Seek care promptly for severe or persistent symptoms.

The pre-switch verification checklist

CheckWhy it mattersWho clears it today
Clinician review, never automatic approvalA licensed clinician who can decline or adjust is the safety layer. A site promising guaranteed approval is a red flag.All 8 ranked providers; HealthRx states it explicitly
Licensed 503A compounding pharmaciesThe compound is only as good as the pharmacy preparing it - state licensure is the quality floor.embody and HealthRx name 503A fulfillment
LegitScript certificationIndependent, revocable certification of the telehealth operation itself.embody; HealthRx (cert. 50087439)
Cold-chain, tracked shippingSemaglutide and tirzepatide are temperature-sensitive; injectables should arrive cold, with ice packs, fast.embody (1-2 days); HealthRx (overnight)
Price at YOUR dose, not the headlineSwitchers often arrive mid-titration; per-dose pricing can beat the advertised rate out of you.Flat at every dose: wellmedr, altRx, DirectMeds, embody

Where switchers land: the price index

The same verified index from our cheapest GLP-1 ranking - real published prices, cheapest first, conditions disclosed.

1wellmedrLowest price

Lowest ongoing price on the market - same price at every dose

Ships in 3-5 business days · Trustpilot 4.6 across 2,091 reviews

Semaglutide

$49/mo

12-month plan; locked for life

Tirzepatide

$89/mo

shipped every 4 weeks

Cheapest with no commitment - month to month, ships in 1-2 days

Ships in 1-2 days, cold-chain · Trustpilot 3.8 across 8,398 reviews

Semaglutide

$69/mo

reg. $79; month-to-month

Tirzepatide

$119/mo

reg. $129; month-to-month

Flat pricing at every dose, plus a real brand-name shelf

Free shipping in 5-7 days · No published Trustpilot rating

Semaglutide

$89/mo

reg. $199; flat at every dose

Tirzepatide

$149/mo

reg. $299; flat at every dose

All-inclusive care: visits, dietician and coaching in the price

Free shipping · Trustpilot 4.3 across 14,836 reviews

Semaglutide

$99/mo

promo; reg. $199 - all-inclusive

Tirzepatide

$166/mo

promo; reg. $299

All-in prepaid year with overnight cold-chain delivery

Overnight cold-chain shipping · No published Trustpilot rating

Semaglutide

$99/mo

12-mo prepaid - $1,188 at checkout

Tirzepatide

from $179/mo

per month

One flat price for both medications - injections or drops

Free 1-2 day shipping · Trustpilot 4.6 across 15,690 reviews

Semaglutide

$147/mo

flat at every dose

Tirzepatide

$147/mo

flat at every dose

Compounded plans plus a brand-name Wegovy option

Prescription shipped within 2 days · Trustpilot 4.1 across 188 reviews

Semaglutide

$149/mo

starting price

Tirzepatide

$199/mo

starting price

Custom dosing with unlimited provider check-ins

Free tracked delivery, often next-day · Trustpilot 3.7 across 5,670 reviews

Semaglutide

$149/mo

same price at every dose; $140 discount applied

Tirzepatide

$259/mo

per month

Coaching included and a 5%-in-120-days money-back guarantee

Home delivery included · Trustpilot 4.6 across 1,134 reviews

Semaglutide

$199/mo

20% off month one

Tirzepatide

$299/mo

20% off month one

Switching From Ozempic: FAQs

Can I switch from Ozempic to compounded semaglutide?

Yes - this is one of the most common paths onto telehealth GLP-1 programs. Ozempic's active ingredient is semaglutide, and compounded semaglutide is the same molecule prepared by a state-licensed compounding pharmacy. You complete the new provider's medical intake, disclose your current medication and dose, and a licensed clinician decides your starting dose on the new program. Compounded products are not FDA-approved brand drugs, so provider and pharmacy quality matter - see what to verify below.

How much cheaper is compounded semaglutide than Ozempic?

Substantially. On our providers' own brand shelves, Ozempic lists at $1,149-$1,399/month and Wegovy at $1,579/month, while compounded semaglutide runs $49-$199/month depending on the provider and plan. Even at the most expensive compounded tier, the difference is roughly $950/month - over $11,000 a year.

Will I keep my current dose when I switch?

That's the reviewing clinician's call, and it's made from your intake - which is why disclosing your exact current medication and dose matters. Many providers charge the same price at every dose (wellmedr, altRx, DirectMeds, embody), so a higher continuation dose doesn't cost more at those programs. Never adjust your own dose during a switch without clinical guidance.

What about switching from Zepbound or Mounjaro?

Same logic, different molecule: Zepbound and Mounjaro are tirzepatide, and compounded tirzepatide is available from $89/month (wellmedr) to $299/month (SHED), versus $1,249-$1,599/month for brand Zepbound. Disclose your current dose in the intake exactly as you would with semaglutide.

Is switching to compounded safe?

The molecule is the same, but compounded products are not FDA-approved brand drugs and quality depends on the pharmacy. Reduce that risk the same way we rank providers: require a real clinician review (never automatic approval), state-licensed 503A pharmacies, LegitScript certification where available (embody, HealthRx), and cold-chain shipping for injectables. And talk to your current prescriber - continuity of care beats a silent switch.

Do I need to tell my current doctor?

You should. The telehealth provider's clinician takes over prescribing, but your own doctor knowing your full medication picture is basic safety - especially if you have other conditions or prescriptions. There's no penalty for switching; brand prescriptions simply lapse when you stop filling them.

More GLP-1 guides

The rest of our weight-loss medication guides, kept to the same verified-price standard.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)

Ozempic, Wegovy, Mounjaro, Zepbound and Rybelsus are trademarks of their respective manufacturers and are not affiliated with treatmentshub.com. Compounded medications are not FDA-approved brand drugs. This page is for information only and is not medical advice - always consult a licensed clinician about switching or starting any medication.